S. Brugaletta

发表

P. Serruys, A. Íñiguez, A. Regueiro, 2015, Revista espanola de cardiologia.

Antithrombotic Therapy in Acute Coronary Syndrome: Striking a Happy Medium.

S. Brugaletta, F. Costa, 2018, Revista espanola de cardiologia.

Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial

S. Cook, P. Sinnaeve, G. Helft, 2018, The Lancet.

Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography.

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2011, JACC. Cardiovascular interventions.

Three-dimensional printing of an aortic model for transcatheter aortic valve implantation: possible clinical applications

O. Camara, S. Brugaletta, V. Martin-Yuste, 2017, The International Journal of Cardiovascular Imaging.

Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT

P. Serruys, S. Garg, H. Garcia-Garcia, 2011, The International Journal of Cardiovascular Imaging.

Percutaneous Transcatheter Aortic Valve Implantation: A Review Focus on Outcomes and Safety

S. Brugaletta, M. Sabaté, L. Ortega‐Paz, 2015 .

Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement.

A. Colombo, L. Conradi, S. Brugaletta, 2021, International journal of cardiology.

Incidence , and Predictors of Antiplatelet Therapy Discontinuation During the First Year After Drug-Eluting Stent Implantation

A. Íñiguez, J. Marsal, S. Brugaletta, 2010 .

Background, Incidence, and Predictors of Antiplatelet Therapy Discontinuation During the First Year After Drug-Eluting Stent Implantation

A. Íñiguez, J. Marsal, S. Brugaletta, 2010, Circulation.

The Role of Antiplatelet Therapy in Patients With MINOCA

S. Brugaletta, D. Angiolillo, D. Capodanno, 2022, Frontiers in Cardiovascular Medicine.

Consensus document of the Interventional Cardiology and Heart Rhythm Associations of the Spanish Society of Cardiology on the management of invasive cardiac procedure rooms during the COVID-19 coronavirus outbreak

S. Brugaletta, I. Cruz-González, D. Calvo, 2020, REC: interventional cardiology (English Edition).

Factors determining success in percutaneous revascularization of chronic total coronary occlusion: multidetector computed tomography analysis.

F. Carreras, S. Pujadas, S. Brugaletta, 2012, Revista espanola de cardiologia.

New Interventional Therapies beyond Stenting to Treat ST-Segment Elevation Acute Myocardial Infarction

S. Brugaletta, M. Sabaté, Pablo Vidal-Calés, 2021, Journal of cardiovascular development and disease.

Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial.

A. M. Leone, G. Niccoli, I. Porto, 2008, International journal of cardiology.

A Positive FFR in the Absence of Visible Stenosis: Where Is the Problem?

S. Brugaletta, 2016 .

Assessment of coronary atherosclerosis progression and regression at bifurcations using combined IVUS and OCT.

P. Serruys, J. Wykrzykowska, H. Garcia-Garcia, 2011, JACC. Cardiovascular imaging.

Latest STEMI treatment: a focus on current and upcoming devices

S. Brugaletta, M. Sabaté, E. Moscarella, 2018, Expert review of medical devices.

ST-segment elevation myocardial infarction – ideal scenario for bioresorbable vascular scaffold implantation?

S. Brugaletta, M. Sabaté, G. Scalone, 2015, Circulation journal : official journal of the Japanese Circulation Society.

Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability.

F. Crea, S. Brugaletta, S. Giubilato, 2009, European heart journal.

Use of the Instantaneous Wave‐free Ratio or Fractional Flow Reserve in PCI

A. Jeremias, P. Serruys, G. Niccoli, 2017, The New England journal of medicine.

New insights into the coronary artery bifurcation hypothesis-generating concepts utilizing 3-dimensional optical frequency domain imaging.

Salvatore Brugaletta, Takayuki Okamura, P. Serruys, 2011, JACC. Cardiovascular interventions.

Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes.

A. Jeremias, P. Serruys, G. Niccoli, 2018, JACC. Cardiovascular interventions.

Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design.

S. Pocock, A. Íñiguez, A. Fernández-Ortiz, 2020, American heart journal.

Magnesium-Based Resorbable Scaffold versus Permanent Metallic SirolimusEluting Stent in Patients with ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial.

A. Íñiguez, B. García del Blanco, S. Brugaletta, 2019, Circulation.

Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention?

P. Serruys, A. Íñiguez, M. Valgimigli, 2019, Circulation. Cardiovascular interventions.

Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment

Manesh R. Patel, A. Jeremias, P. Serruys, 2019, Journal of the American College of Cardiology.

Platelet reactivity assessment with VerifyNow®: substitute or complement for light transmission aggregometry?

M. Díaz-Ricart, G. Escolar, A. Regueiro, 2015, International journal of cardiology.

RAndomized Comparison of raDIal vs. femorAL Access for Routine Catheterization of Heart Transplant Patients (RADIAL-heart transplant study).

S. Brugaletta, V. Martin-Yuste, M. Sabaté, 2014, Transplantation proceedings.

Lumen enlargement of the coronary segments located distal to chronic total occlusions successfully treated with drug-eluting stents at follow-up.

S. Brugaletta, Á. Cequier, J. Ferreiro, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.

J. Reiber, P. Serruys, A. Íñiguez, 2022, American heart journal.

Treatment of device related thrombosis after left atrial appendage occlusion: Initial experience with low-dose apixaban.

M. Sitges, A. Regueiro, S. Brugaletta, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Medical management of connector pin thrombosis with the Amplatzer cardiac plug left atrial closure device.

A. Regueiro, D. Fernández-Rodríguez, S. Brugaletta, 2013, World journal of cardiology.

Can new generation P2Y12 inhibitors play a role in microvascular obstruction in STEMI?

L. Badimón, S. Brugaletta, M. Sabaté, 2016, International journal of cardiology.

Randomized comparison of optical coherence tomography versus angiography to guide Bioresorbable vascular scaffold implantation: The OPTICO BVS study.

L. Räber, F. Burzotta, S. Cook, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve-Guided Revascularization Strategy.

Manesh R. Patel, A. Jeremias, P. Serruys, 2019, JACC. Cardiovascular interventions.

2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent.

H. Thiele, A. Baumbach, A. Lansky, 2019, JACC. Cardiovascular interventions.

One-year results following a pre-specified ABSORB implantation strategy in ST-elevation myocardial infarction (BVS STEMI STRATEGY-IT study).

G. Campo, S. Brugaletta, A. Ielasi, 2019, Cardiovascular revascularization medicine : including molecular interventions.

Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial

H. Thiele, A. Baumbach, A. Lansky, 2018, The Lancet.

A Prospective Evaluation of a Pre-Specified Absorb BVS Implantation Strategy in ST-Segment Elevation Myocardial Infarction: The BVS STEMI STRATEGY-IT Study.

G. Campo, S. Brugaletta, A. Ielasi, 2017, JACC. Cardiovascular interventions.

A prospective evaluation of a standardized strategy for the use of a polymeric everolimus‐eluting bioresorbable scaffold in ST‐segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY‐IT study

G. Campo, S. Brugaletta, A. Ielasi, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study).

C. Di Mario, C. Templin, G. Campo, 2016, International journal of cardiology.

Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial

Sunil V. Rao, P. Jüni, M. Valgimigli, 2015, The Lancet.

Three-year results of ST-segment elevation myocardial infarction patients treated with a prespecified bioresorbable vascular scaffold implantation strategy: bVS STEMI STRATEGY-IT long-term

Bruno Loi, G. Campo, S. Brugaletta, 2021, Journal of cardiovascular medicine.

Out-of-hospital cardiac arrest and stent thrombosis: Ticagrelor versus clopidogrel in patients with primary percutaneous coronary intervention under mild therapeutic hypothermia.

A. Regueiro, S. Brugaletta, M. Masotti, 2017, Resuscitation.

Cost‐effectiveness of percutaneous coronary intervention with cobalt‐chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta‐analysis of randomized trials

F. Eberli, P. Serruys, M. Valgimigli, 2016, Catheterization and cardiovascular interventions.

Bioresorbable scaffolds: should we stay simple or go complex?

H. Garcia-Garcia, S. Brugaletta, M. Sabaté, 2017, Cardiovascular diagnosis and therapy.

Safety of glycoprotein IIb/IIIa inhibitors in patients under therapeutic hypothermia admitted for an acute coronary syndrome.

M. Roqué, S. Brugaletta, M. Masotti, 2016, Resuscitation.

Impact of Body Mass Index on 5-Year Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction After Everolimus-Eluting or Bare-Metal Stent Implantation.

P. Serruys, A. Íñiguez, M. Valgimigli, 2017, The American journal of cardiology.

Impact of SGLT2i on cardiovascular outcomes and heart failure in patients with type 2 diabetes

J. J. Rodríguez, S. Brugaletta, M. Sabaté, 2018 .

Ten-year patterns of stent thrombosis after percutaneous coronary intervention with new- versus early-generation drug-eluting stents: insights from the DECADE cooperation.

L. Räber, A. Kastrati, S. Windecker, 2022, Revista espanola de cardiologia.

1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.

J. Mehilli, C. Di Mario, A. Colombo, 2016, JACC. Cardiovascular interventions.

Evaluation of a strategy for treating bifurcated lesions by single or double stenting based on the Medina classification.

A. M. Leone, F. Burzotta, C. Trani, 2009, Revista espanola de cardiologia.

TIcaGrEloR and Absorb bioresorbable vascular scaffold implantation for recovery of vascular function after successful chronic total occlusion recanalization (TIGER‐BVS trial): Rationale and study design

S. Brugaletta, M. Sabaté, Á. Cequier, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-Term Coronary Functional Assessment of the Infarct-Related Artery Treated With Everolimus-Eluting Bioresorbable Scaffolds or Everolimus-Eluting Metallic Stents: Insights of the TROFI II Trial.

P. Serruys, S. Windecker, S. Brugaletta, 2018, JACC. Cardiovascular interventions.

Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study.

L. Räber, S. Windecker, S. Rimoldi, 2018, JACC. Cardiovascular interventions.

Optical coherence tomography appraisal of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing intraprocedural versus post-stenting prolonged bivalirudin infusion. Rationale and design of the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Acc

H. Garcia-Garcia, M. Valgimigli, E. Regar, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry.

M. Jeong, F. Neumann, S. Ellis, 2013, International journal of cardiology.

A serial three- and nine-year optical coherence tomography evaluation of neoatherosclerosis progression after sirolimus- and paclitaxel- -eluting stent implantation.

J. Jąkała, S. Brugaletta, M. Tomaniak, 2018, Kardiologia polska.

Outcomes in the EXAMINATION trial – Authors' reply

S. Brugaletta, M. Sabaté, 2016, The Lancet.

Sex-based differences in chronic total occlusion management and long-term clinical outcomes.

M. Roqué, M. Farrero, A. Regueiro, 2020, International journal of cardiology.

Vascular Injury After Stenting　- Insights of Systemic Mechanisms of Vascular Repair.

C. Macaya, A. Fernández-Ortiz, S. Brugaletta, 2021, Circulation journal : official journal of the Japanese Circulation Society.

Comparison of clinical outcomes in STEMI patients treated with primary PCI according to day-time of medical attention and its relationship with circadian pattern.

A. Regueiro, S. Brugaletta, M. Masotti, 2020, International journal of cardiology.

The importance of organizational variables in treatment time for patients with ST-elevation acute myocardial infarction improve delays in STEMI.

S. Brugaletta, J. García-Picart, M. M. Martínez Momblan, 2020, Australasian emergency care.

Baseline Risk Stratification of Patients Older Than 75 Years With Infarction and Cardiogenic Shock Undergoing Primary Angioplasty.

S. Brugaletta, F. Alfonso, N. Salvatella, 2019, Revista espanola de cardiologia.

False Positive STEMI Activations in a Regional Network: Comprehensive Analysis and Clinical Impact. Results From the Catalonian Codi Infart Network.

M. Roqué, A. Regueiro, D. Fernández-Rodríguez, 2017, Revista espanola de cardiologia.

Thrombectomy and Stroke: Guilty or Innocent Bystander?

S. Brugaletta, M. Sabaté, 2018, Journal of the American College of Cardiology.

Primary Angioplasty in Patients Older Than 75 Years. Profile of Patients and Procedures, Outcomes, and Predictors of Prognosis in the ESTROFA IM+75 Registry.

S. Brugaletta, F. Alfonso, N. Salvatella, 2017, Revista espanola de cardiologia.

Optimization in Stent Implantation by Manual Thrombus Aspiration in ST-Segment–Elevation Myocardial Infarction: Findings From the EXAMINATION Trial

P. Serruys, A. Íñiguez, M. Valgimigli, 2014, Circulation. Cardiovascular interventions.

Everolimus-eluting stent versus bare metal stent in proximal left anterior descending ST-elevation myocardial infarction: insights from the EXAMINATION trial.

P. Serruys, A. Íñiguez, M. Valgimigli, 2013, American heart journal.

Role of the CD14 C(−260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease

E. Trabetti, P. Pignatti, F. Crea, 2010, Journal of cardiovascular medicine.

Unusual CD4+CD28nullT Lymphocytes and Recurrence of Acute Coronary Events

A. Rebuzzi, F. Crea, A. Maseri, 2007 .

Modulation of CD4 (cid:1) CD28 null T Lymphocytes by Tumor Necrosis Factor- (cid:2) Blockade in Patients With Unstable Angina

A. Rebuzzi, F. Crea, S. Brugaletta, 2006 .

Mid-term effects of SARS-CoV-2 infection on cardiovascular outcomes

S. Brugaletta, L. Ortega‐Paz, Victor Arévalos, 2022, Medicina Clínica (English Edition).

Mid-term effects of SARS-CoV-2 infection on cardiovascular outcomes

S. Brugaletta, L. Ortega‐Paz, Victor Arévalos, 2021, Medicina Clínica.

Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II stu

P. Serruys, L. Räber, A. Íñiguez, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Methods to assess bioresorbable vascular scaffold devices behaviour after implantation.

S. Brugaletta, Kohki Ishida, E. Moscarella, 2017, Journal of thoracic disease.

TCT-49 Two-year clinical outcome of Everolimus-eluting bioresorbable scaffold vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.

P. Serruys, S. Windecker, S. Brugaletta, 2016, Journal of the American College of Cardiology.

Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective.

S. Achenbach, J. Mehilli, C. Di Mario, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Everolimus-eluting stent versus bare-metal stent in elderly (≥75 years) versus non-elderly (<75 years) patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the examination trial.

P. Serruys, A. Íñiguez, M. Valgimigli, 2015, International journal of cardiology.

Angina and Ischemia at 2 Years With Bioresorbable Vascular Scaffolds and Metallic Drug-eluting Stents. ESTROFA Ischemia BVS-mDES Study.

Mireia Blé, S. Brugaletta, M. Sabaté, 2017, Revista espanola de cardiologia.

A longer look at trial evidence of bioresorbable vascular scaffolds

S. Brugaletta, M. Sabaté, 2017, Heart.

ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison.

P. Serruys, Chi‐Hang Lee, A. Low, 2016, International journal of cardiology.

Evaluation of in-stent restenosis in the APPROACH trial (assessment on the prevention of progression by Rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history)

Diane M. Miller, P. Serruys, S. Garg, 2011, The International Journal of Cardiovascular Imaging.

Correlation between kidney function and near-infrared spectroscopy derived lipid-core burden index score of a non-intervened coronary artery segment.

P. Serruys, H. Garcia-Garcia, S. D. de Boer, 2012, International journal of cardiology.

Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial

P. Serruys, A. Íñiguez, Z. Ademi, 2018, PloS one.

C-Reactive Protein and Other Inflammatory Biomarkers as Predictors of Outcome Following Acute Coronary Syndromes

A. Abbate, S. Brugaletta, G. Biondi‐Zoccai, 2003, Seminars in vascular medicine.

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation

S. Brugaletta, M. Sabaté, F. Alfonso, 2021, Journal of the American Heart Association.

Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial.

R. Whitbourn, P. Serruys, H. Garcia-Garcia, 2012, JACC. Cardiovascular interventions.

Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up.

Bernard Chevalier, Patrick W Serruys, Richard Rapoza, 2011, JACC. Cardiovascular interventions.

Risk of target lesion failure in relationship to vessel angiographic geometry and stent conformability using the second generation of drug-eluting stents.

P. Serruys, S. Silber, S. Garg, 2011, American heart journal.

Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol

G. Campo, D. Fernández-Rodríguez, S. Brugaletta, 2021, PloS one.

Myocardial Injury in COVID-19 Patients: Association with Inflammation, Coagulopathy and In-Hospital Prognosis

M. Roqué, S. Brugaletta, M. Sabaté, 2021, Journal of clinical medicine.

Percutaneous Treatment of Extremely Small Coronary Vessels: Does Size Matter in Terms of Performance?

S. Brugaletta, M. Sabaté, 2017, JACC. Cardiovascular interventions.

Very Late Scaffold Thrombosis

F. Eberli, P. Serruys, L. Räber, 2022 .

Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy.

R. Ferrari, M. Valgimigli, G. Campo, 2010, Journal of the American College of Cardiology.

Multivessel disease in patients over 75years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI+75 nation-wide registry.

S. Brugaletta, F. Alfonso, N. Salvatella, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry.

J. Mehilli, C. Di Mario, A. Colombo, 2017, JACC. Cardiovascular interventions.

Comparison of plaque prolapse in consecutive patients treated with Xience V and Taxus Liberte stents

P. Serruys, H. Garcia-Garcia, S. Brugaletta, 2010, The International Journal of Cardiovascular Imaging.

Functional and Morphological Assessment of Left Anterior Descending Artery in Patients With Tako-tsubo Syndrome.

S. Brugaletta, M. Sabaté, I. Amat-Santos, 2017, Revista espanola de cardiologia.

TCT-213 Everolimus-eluting stent versus bare metal stent in proximal left anterior descending ST-elevation myocardial infarction

S. Brugaletta, Á. Cequier, M. Sabaté, 2013 .

Darapladib effect on circulating high sensitive troponin in patients with acute coronary syndromes.

P. Serruys, H. Garcia-Garcia, E. Boersma, 2012, Atherosclerosis.

Circulating miRNA Fingerprint and Endothelial Function in Myocardial Infarction: Comparison at Acute Event and One-Year Follow-Up

C. Hermenegildo, S. Brugaletta, M. Sabaté, 2022, Cells.

Cardiogenic Shock in STEMI

S. Brugaletta, 2020 .

Role of Quantitative Flow Ratio in Predicting Future Cardiac Allograft Vasculopathy in Heart Transplant Recipients

L. Potena, M. Farrero, G. Campo, 2022, Circulation. Cardiovascular interventions.

Does manual thrombus aspiration help optimize stent implantation in ST-segment elevation myocardial infarction?

M. de Antonio, D. Fernández-Rodríguez, S. Brugaletta, 2014, World journal of cardiology.

Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST‐EU Registry

J. Mehilli, C. Di Mario, A. Colombo, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes.

S. Windecker, M. Valgimigli, A. Santarelli, 2018, Journal of the American College of Cardiology.

Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial

E. Bramucci, E. D. Lorenzo, E. Romagnoli, 2018, The Lancet.

Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry).

A. Íñiguez, F. Fernández‐Avilés, B. García del Blanco, 2016, The American journal of cardiology.

Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events.

A. Rebuzzi, F. Crea, A. Maseri, 2007, Journal of the American College of Cardiology.

Expansion of CD4 1 CD28 null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus

F. Crea, S. Brugaletta, S. Giubilato, 2011 .

Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study).

A. M. Leone, F. Burzotta, G. Niccoli, 2007, The American journal of cardiology.

Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients With ST-Segment–Elevation Myocardial Infarction and Multivessel Disease

A. M. Leone, J. Reiber, C. Trani, 2018, Circulation. Cardiovascular interventions.

Letter by Brugaletta et al regarding article, "Vascular reactivity and flow characteristics of radial artery and long saphenous vein coronary bypass grafts: a 5-year follow-up".

S. Brugaletta, V. Martin-Yuste, M. Sabaté, 2011, Circulation.

Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD.

D. Andreini, P. Serruys, R. D. de Winter, 2018, Journal of the American College of Cardiology.

Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry.

J. Mehilli, C. Di Mario, A. Colombo, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Radial versus femoral access for angioplasty of ST-segment elevation acute myocardial infarction with second-generation drug-eluting stents.

P. Serruys, A. Íñiguez, S. Brugaletta, 2015, Revista espanola de cardiologia.

Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study

B. Uretsky, G. Campo, S. Brugaletta, 2021, Cardiovascular Drugs and Therapy.

Edge vascular response after polymer-free vs. polymer-based paclitaxel-eluting stent implantation.

B. García del Blanco, S. Brugaletta, V. Martin-Yuste, 2014, Circulation journal : official journal of the Japanese Circulation Society.

Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease

S. Saito, A. Baumbach, J. Wykrzykowska, 2021 .

Outcomes of Nonagenarians With ST Elevation Myocardial Infarction.

A. Regueiro, S. Brugaletta, M. Masotti, 2019, The American journal of cardiology.

MAGnesium‐based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design

A. Íñiguez, S. Brugaletta, Á. Cequier, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study.

G. Campo, S. Brugaletta, M. Sabaté, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of PSP Technique on Clinical Outcomes Following Bioresorbable Scaffolds Implantation

S. Brugaletta, M. Sabaté, L. Ortega‐Paz, 2018, Journal of clinical medicine.

Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry.

J. Mehilli, C. Di Mario, A. Colombo, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary ste

P. Serruys, Chi‐Hang Lee, A. Low, 2015, JACC. Cardiovascular interventions.

Gender Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial.

P. Serruys, A. Íñiguez, M. Lenzen, 2022, JACC. Cardiovascular interventions.

Comments on the 2018 ESC Fourth Universal Definition of Myocardial.

A. Evangelista, H. Bueno, B. Ibáñez, 2019, Revista espanola de cardiologia.

[Benefit of the implementation of a ST-segment elevation myocardial infarction network on women].

A. Regueiro, D. Fernández-Rodríguez, S. Brugaletta, 2015, Archivos de cardiologia de Mexico.

Perspective on the use of true vessel characterization imaging in interventional cardiology clinical practice

P. Serruys, H. Garcia-Garcia, S. Brugaletta, 2011 .

Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial.

S. de Servi, S. Windecker, M. Valgimigli, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy.

V. Ribeiro, J. Reiber, P. Serruys, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Novel anti-inflammatory effect of statins: reduction of CD4+CD28null T lymphocyte frequency in patients with unstable angina

G. Biondi-Zoccai, F. Crea, S. Brugaletta, 2006, Heart.

Impact of chronic kidney disease in chronic total occlusion management and clinical outcomes.

M. Roqué, A. Regueiro, S. Brugaletta, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Minimally Invasive Transradial Percutaneous Closure of Aortic Paravalvular Leaks: Following the Steps of Percutaneous Coronary Intervention.

S. Brugaletta, V. Martin-Yuste, M. Masotti, 2016, The Canadian journal of cardiology.

Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial.

P. Serruys, A. Íñiguez, M. Valgimigli, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Cell-free DNA and Microvascular Damage in ST-segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.

J. Núñez, S. Brugaletta, M. Sabaté, 2019, Revista espanola de cardiologia.

Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion

M. Sitges, A. Regueiro, S. Brugaletta, 2021, Journal of cardiovascular development and disease.

The use of the acute Pd/Pa drop after intracoronary nitroglycerin infusion to rule out significant FFR: CANICA (Can intracoronary nitroglycerin predict fractional flow reserve without adenosine?) multicenter study

S. Brugaletta, R. Lopez-Palop, J. M. de la Torre Hernández, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

First-in-man, last in evidence?

S. Brugaletta, M. Sabaté, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Experience With the Absorb Bioresorbable Vascular Scaffold in Various Scenarios of Congenital Heart Disease

S. Brugaletta, M. Sabaté, I. Amat-Santos, 2019 .

Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy

A. Regueiro, S. Brugaletta, M. Masotti, 2021, Journal of clinical medicine.

Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation insights from the ABSORB B trial.

R. Whitbourn, P. Serruys, S. Windecker, 2011, JACC. Cardiovascular interventions.

A 12–month angiographic and optical coherence tomography follow‐up after bioresorbable vascular scaffold implantation in patients with ST‐segment elevation myocardial infarction

J. Jąkała, S. Brugaletta, M. Tomaniak, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Endothelial and smooth muscle cells dysfunction distal to recanalized chronic total coronary occlusions and the relationship with the collateral connection grade.

P. Serruys, F. Crea, H. Garcia-Garcia, 2012, JACC. Cardiovascular interventions.

Connection Grade Chronic Total Coronary Occlusions and the Relationship With the Collateral Endothelial and Smooth Muscle Cells Dysfunction Distal to Recanalized

P. Serruys, F. Crea, H. Garcia-Garcia, 2012 .

Longitudinal neointimal distribution pattern after Everolimus-eluting stent implantation: Insights from optical coherence tomography study.

S. Brugaletta, M. Masotti, M. Sabaté, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis?

S. Brugaletta, M. Sabaté, G. Giacchi, 2016, Cardiovascular revascularization medicine : including molecular interventions.

First experience of a bioresorbable vascular scaffold implantation in left main stenosis.

A. Regueiro, S. Brugaletta, V. Martin-Yuste, 2013, International journal of cardiology.

Zotarolimus for the treatment of coronary artery disease: pathophysiology, DES design, clinical evaluation and future perspective.

F. Burzotta, S. Brugaletta, M. Sabaté, 2009, Expert opinion on pharmacotherapy.

Surgical Risk Scoring in TAVR: Still Needed? A Metaregression Analysis.

S. Brugaletta, F. Cura, P. Lamelas, 2021, Current problems in cardiology.

How should I treat a bioresorbable vascular scaffold edge restenosis and intra-scaffold dissection?

Seung‐Jung Park, S. Brugaletta, Seung‐Whan Lee, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Bioresorbable drug-eluting stent implantation technique: In search of a magic recipe.

S. Brugaletta, M. Sabaté, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: Insights from the ABSORB and SPIRIT trials

P. Serruys, H. Garcia-Garcia, D. Dudek, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study)

G. Niccoli, A. Rebuzzi, F. Crea, 2006, Heart.

Impact of Pulmonary Ridge Coverage after Left Atrial Appendage Occlusion.

M. Roqué, M. Sitges, A. Regueiro, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy

B. Uretsky, G. Campo, S. Brugaletta, 2022, The International Journal of Cardiovascular Imaging.

Letter by Ortega-Paz et al Regarding Article, "East Asian Variant of Aldehyde Dehydrogenase 2 Is Associated With Coronary Spastic Angina: Possible Roles of Reactive Aldehydes and Implications of Alcohol Flushing Syndrome".

S. Brugaletta, L. Ortega‐Paz, G. Giacchi, 2015, Circulation.

The "RotaTripsy Plus" approach in a heavily calcified coronary stenosis.

S. Brugaletta, G. Giacchi, G. Ruscica, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry.

A. Colombo, S. Brugaletta, F. D’Ascenzo, 2022, International journal of cardiology.

Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial).

P. Serruys, A. Íñiguez, M. Valgimigli, 2018, The American journal of cardiology.

Cardiac embolism after implantable cardiac defibrillator shock in non-anticoagulated atrial fibrillation: The role of left atrial appendage occlusion.

D. Fernández-Rodríguez, S. Brugaletta, V. Martin-Yuste, 2014, World journal of cardiology.

Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TRO

P. Serruys, L. Räber, R. D. de Winter, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Distance of lipid core-rich plaques from the ostium by NIRS in nonculprit coronary arteries.

P. Serruys, H. Garcia-Garcia, S. D. de Boer, 2012, JACC. Cardiovascular imaging.

Effects of Ticagrelor, Prasugrel, or Clopidogrel at Steady State on Endothelial Function.

S. Windecker, S. Rimoldi, M. Valgimigli, 2018, Journal of the American College of Cardiology.

Organized thrombus, disorganized heart.

S. Brugaletta, V. Martin-Yuste, M. Sabaté, 2013, Circulation journal : official journal of the Japanese Circulation Society.

Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial).

P. Serruys, L. Räber, A. Íñiguez, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Acute Absorb bioresorbable vascular scaffold thrombosis in ST-segment elevation myocardial infarction: to stent or not to stent?

D. Fernández-Rodríguez, S. Brugaletta, M. Sabaté, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[Absorb BVS: quo vadis?]

S. Brugaletta, A. Pernigotti, 2016, Giornale italiano di cardiologia.

Long-term vascular function in CTO recanalization: A randomized clinical trial of ticagrelor vs. clopidogrel.

S. Brugaletta, M. Sabaté, J. Gómez-Lara, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Ticagrelor versus clopidogrel for recovery of vascular function immediately after successful chronic coronary total occlusion recanalization: A randomized clinical trial

S. Brugaletta, M. Sabaté, Á. Cequier, 2018, American heart journal.

Healing of a coronary artery dissection detected by intravascular ultrasound and optical coherence tomography.

P. Serruys, H. Garcia-Garcia, E. Regar, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A Randomized Comparison of Reservoir-Based Polymer-Free Amphilimus-Eluting Stents Versus Everolimus-Eluting Stents With Durable Polymer in Patients With Diabetes Mellitus: The RESERVOIR Clinical Trial.

M. Valgimigli, A. Fernández-Ortiz, E. Montanya, 2016, JACC. Cardiovascular interventions.

STEMI With a Massive Coronary Aneurysm

S. Brugaletta, E. Flores-Umanzor, J. Ponte Monteiro, 2020, JACC. Case reports.

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents. A pooled analysis of individual patient data from 2 randomized trials.

P. Serruys, L. Räber, A. Íñiguez, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

CRosser As First choice for crossing Totally occluded coronary arteries (CRAFT Registry): focus on conventional angiography and computed tomography angiography predictors of success.

P. Serruys, H. Garcia-Garcia, C. V. van Mieghem, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Acute myocardial infarction, primary percutaneous coronary intervention and stent thrombosis in heart transplanted patient: Potential role of elevated coagulation factor VIII

M. Farrero, A. Regueiro, S. Brugaletta, 2014 .

Case report - Special issue: Acute Coronary Syndromes Acute myocardial infarction, primary percutaneous coronary intervention and stent thrombosis in heart transplanted patient: Potential role of elevated coagulation factor VIII

M. Farrero, A. Regueiro, S. Brugaletta, 2014 .

Amphilimus- versus everolimus-eluting stents in patients with diabetes mellitus: 5-year follow-up of the RESERVOIR trial

S. Brugaletta, M. Sabaté, P. Jiménez-Quevedo, 2022, Cardiovascular Revascularization Medicine.

Thrombocytopenia after transcatheter aortic valve implantation. A comparison between balloon‐expandable and self‐expanding valves

A. Regueiro, S. Brugaletta, V. Martin-Yuste, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Could Plaque Composition-Related Endothelial Dysfunction Predict Poor Prognosis in Coronary Vasospastic Angina?

H. Garcia-Garcia, S. Brugaletta, L. Ortega‐Paz, 2016, Journal of the American College of Cardiology.

Coronary artery lesion phenotype in frail older patients with non-ST-elevation acute coronary syndrome undergoing invasive care.

W. Qiu, G. Mintz, G. Ford, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention.

S. Brugaletta, V. Martin-Yuste, M. Sabaté, 2011, World journal of cardiology.

Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction

E. Ortega, S. Brugaletta, M. Sabaté, 2022, ESC heart failure.

Vascular healing responses to paclitaxel coated balloons or everolimus eluting stents for the treatment of in-stent restenosis. Insights from optical coherence tomography

C. Macaya, A. Fernández-Ortiz, S. Brugaletta, 2022, Coronary artery disease.

Initial Results after the Implementation of an Edge-To-Edge Transcatheter Tricuspid Valve Repair Program

M. Sitges, M. Farrero, A. Regueiro, 2021, Journal of clinical medicine.

3D reconstructions of optical frequency domain imaging to improve understanding of conventional PCI.

P. Serruys, H. Garcia-Garcia, B. Gogas, 2011, JACC. Cardiovascular imaging.

Ruptured Thin-Cap Fibroatheroma as Cause of Recurrent Stemi and Malignant Arrhythmias

S. Brugaletta, M. Sabat, L. Ortega‐Paz, 2015 .

Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease

S. Saito, A. Baumbach, J. Wykrzykowska, 2021, Circulation.

May LAAO Learning Curve Explain the Relationship Between Procedural Volume and Complications Rate?

S. Brugaletta, X. Freixa, M. Sabaté, 2021, JACC. Cardiovascular interventions.

Levosimendan as an adjunctive therapy to MitraClip implantation in patients with severe mitral regurgitation and left ventricular dysfunction.

M. Sitges, M. Farrero, A. Regueiro, 2016, International journal of cardiology.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

M. Sitges, A. Regueiro, S. Brugaletta, 2020, Journal of Interventional Cardiac Electrophysiology.

Percutaneous Treatment of a Circumflex Artery Occlusion After Minimally Invasive Barlow Disease Mitral Valve Repair

S. Brugaletta, E. Sandoval, L. Ortega‐Paz, 2021, JACC. Case reports.

Utilizing Risk Scores in Determining the Optimal Revascularization Strategy for Complex Coronary Artery Disease

P. Serruys, S. Brugaletta, V. Farooq, 2011, Current cardiology reports.

Very long-term outcome of ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study.

P. Serruys, T. Münzel, E. Schulz, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Data from real-world registries: can it guide development of the bioresorbable scaffolds of tomorrow?

S. Brugaletta, Y. Onuma, L. Ortega‐Paz, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Personalized vascular care: Why it is important?

W. Wijns, S. Brugaletta, 2022, European heart journal supplements : journal of the European Society of Cardiology.

Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial).

P. Serruys, A. Íñiguez, M. Lenzen, 2022, The American journal of cardiology.

Impact of diabetes mellitus on vascular healing process after everolimus-eluting stent implantation: An optical coherence tomography study.

S. Brugaletta, M. Masotti, M. Sabaté, 2021, Cardiovascular revascularization medicine : including molecular interventions.

A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study).

B. García del Blanco, S. Brugaletta, M. Sabaté, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The future of individualized cardiovascular care: how wearables could be integrated to improve outcomes

J. Spratt, S. Brugaletta, John D Hung, 2022, European heart journal supplements : journal of the European Society of Cardiology.

Assessment of atherosclerotic plaques at coronary bifurcations with multidetector computed tomography angiography and intravascular ultrasound-virtual histology.

P. Serruys, H. Garcia-Garcia, G. Krestin, 2012, European heart journal cardiovascular Imaging.

Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives

Patrick W Serruys, Yoshinobu Onuma, Hector M Garcia-Garcia, 2012, Expert review of medical devices.

Disparate miRNA expression in serum and plasma of patients with acute myocardial infarction: a systematic and paired comparative analysis

C. Hermenegildo, S. Brugaletta, M. Sabaté, 2020, Scientific Reports.

Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients.

F. Crea, M. Capogrossi, M. Napolitano, 2009, Physiological genomics.

Comparative Genomics Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients

F. Crea, M. Capogrossi, M. Napolitano, 2009 .

Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention: Results From the Double-Blind, Prospective, Randomized Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance

R. Ferrari, M. Valgimigli, G. Campo, 2009, Circulation.

Randomized Tailoring Treatment With Tirofiban in Clopidogrel , or Both Agents Undergoing Elective Coronary Intervention : Results From Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin

M. Valgimigli, G. Campo, S. Brugaletta, 2009 .

Determinants of high cardiovascular risk in relation to plaque-composition of a non-culprit coronary segment visualized by near-infrared spectroscopy in patients undergoing percutaneous coronary intervention.

P. Serruys, H. Garcia-Garcia, S. D. de Boer, 2014, European heart journal.

Diabetes mellitus: a prothrombotic state Implications for outcomes after coronary revascularization

S. Brugaletta, M. Sabaté, D. Angiolillo, 2009, Vascular health and risk management.

Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly-l-Lactic Acid Coronary Stents: Igaki-Tamai Stents

Yoshinobu Onuma, Takashi Muramatsu, Keiji Igaki, 2012, Circulation.

A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2011, European heart journal.

Optical coherence tomography: A pathway from research to clinical practice.

H. Garcia-Garcia, S. Brugaletta, L. Ortega‐Paz, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process.

R. Whitbourn, P. Serruys, S. Windecker, 2012, JACC. Cardiovascular interventions.

Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus.

F. Crea, S. Brugaletta, S. Giubilato, 2011, European heart journal.

Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation.

F. Crea, A. Maseri, S. Brugaletta, 2007, Journal of the American College of Cardiology.

Acute and Chronic Effects of COVID-19 on the Cardiovascular System

S. Brugaletta, M. Sabaté, L. Ortega‐Paz, 2021, Journal of cardiovascular development and disease.

Best of JACC: Cardiovascular Interventions

P. Serruys, Chi‐Hang Lee, A. Low, 2017 .

Stable coronary artery disease. Is it really stable? Lesion morphology interpretation by Grayscale and VH‐IVUS in patients with coronary artery disease

S. Brugaletta, M. Sabaté, L. Ortega‐Paz, 2016 .

Three-dimensional optical frequency domain imaging in conventional percutaneous coronary intervention: the potential for clinical application.

Patrick W Serruys, Yoshinobu Onuma, Salvatore Brugaletta, 2013, European heart journal.

Can the vicious cycle of obscure or intractable gastrointestinal bleeding be broken in patients with atrial fibrillation subject to anticoagulant therapy?

A. Regueiro, D. Fernández-Rodríguez, S. Brugaletta, 2014, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial

P. Serruys, A. Íñiguez, M. Valgimigli, 2016, The Lancet.

Long‐term impact of diabetes in patients with ST‐segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial

P. Serruys, A. Íñiguez, C. Macaya, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Immunomodulator activity of 3-hydroxy-3-methilglutaryl-CoA inhibitors.

S. Brugaletta, G. Liuzzo, C. Smaldone, 2009, Cardiovascular & hematological agents in medicinal chemistry.

Coronary Microvascular Angina: A State-of-the-Art Review

S. Brugaletta, M. Sabaté, R. Gabani, 2022, Frontiers in Cardiovascular Medicine.

Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial

S. Windecker, M. Valgimigli, C. Briguori, 2016, British Medical Journal.

Frequency and predictors of thrombus inside the guiding catheter during interventional procedures: an optical coherence tomography study

H. Garcia-Garcia, S. Brugaletta, V. Martin-Yuste, 2014, The International Journal of Cardiovascular Imaging.

Contemporary and evolving risk scoring algorithms for percutaneous coronary intervention

P. Serruys, S. Brugaletta, V. Farooq, 2011, Heart.

Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials.

L. Räber, A. Íñiguez, A. Baumbach, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction.

P. Serruys, A. Íñiguez, M. Lenzen, 2021, Journal of the American College of Cardiology.

Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings.

F. Eberli, P. Serruys, L. Räber, 2015, Journal of the American College of Cardiology.

Outcome of patients treated by a novel thin‐strut cobalt‐chromium stent in the drug‐eluting stent era: Results of the SKICE (Skylor in real world practice) registry

F. Burzotta, C. Trani, G. Niccoli, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry.

M. de Antonio, S. Brugaletta, V. Martin-Yuste, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

1059G/C polymorphism within the exon 2 of the C-reactive protein gene: relationship to C-reactive protein levels and prognosis in unstable angina

E. Trabetti, P. Pignatti, F. Crea, 2007, Coronary artery disease.

P Acute Coronary Syndromes Unusual CD 4 CD 28 null T Lymphocytes and Recurrence of Acute Coronary Events

A. Rebuzzi, F. Crea, A. Maseri, 2007 .

P Acute Coronary Syndromes Persistent Activation of Nuclear Factor Kappa-B Signaling Pathway in Patients With Unstable Angina and Elevated Levels of C-Reactive Protein Evidence for a Direct Proinflammatory Effect of Azide and Lipopolysaccharide-Free C-Reactive Protein on Human Monocytes Via Nuclear

F. Crea, A. Maseri, S. Brugaletta, 2006 .

Reproducibility of intravascular ultrasound radiofrequency data analysis (virtual histology) with a 45-MHz rotational imaging catheter in ex vivo human coronary arteries.

P. Serruys, H. Garcia-Garcia, A. Nair, 2015, Journal of cardiology.

Studies Reproducibility of Intravascular Ultrasound iMAP for Radiofrequency Data Analysis : Implications for Design of Longitudinal Studies

P. Serruys, H. Garcia-Garcia, S. Brugaletta, 2014 .

Research Utility of Intravascular Ultrasound

P. Serruys, S. Garg, H. Garcia-Garcia, 2012 .

Correspondence Letter by Brugaletta Et Al regarding Article, " Vascular Reactivity and Flow Characteristics of Radial Artery and Long Saphenous Vein Coronary Bypass Grafts: a 5-year Follow-up "

S. Brugaletta, V. Martin-Yuste, M. Sabaté, 2022 .

Percutaneous transcatheter aortic valve implantation: present and future perspective

Xavier Freixa, Manel Sabaté, Diego Fernández, 2013, Expert review of medical devices.

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

P. Serruys, A. Íñiguez, R. Geuns, 2012, The Lancet.

Rationale and study design of the RESERVOIR trial: A randomized trial comparing reservoir‐based polymer‐free amphilimus‐eluting stents versus everolimus‐eluting stents with durable polymer in patients with diabetes mellitus

M. Valgimigli, E. Montanya, S. Brugaletta, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis

F. Eberli, P. Serruys, M. Valgimigli, 2014, BMJ : British Medical Journal.

Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study.

P. Serruys, L. Räber, S. Windecker, 2014, European heart journal.

Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted Fro

P. Serruys, L. Räber, A. Íñiguez, 2014, JACC. Cardiovascular interventions.

The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.

P. Serruys, A. Íñiguez, M. Valgimigli, 2014, JACC. Cardiovascular interventions.

Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trial.

P. Serruys, A. Íñiguez, M. Valgimigli, 2013, International journal of cardiology.

One‐year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent

Patrick W Serruys, Manel Sabaté, Stephan Windecker, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Paradoxical preservation of vascular function in severe obesity.

F. Crea, S. Brugaletta, C. Guidone, 2010, The American journal of medicine.

Percutaneous Mitral Valve Repair With Mitraclip ® System in a Patient With Acute Mitral Regurgitation After Myocardial Infarction

A. Regueiro, D. Fernández-Rodríguez, S. Brugaletta, 2018 .

Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction.

P. Serruys, G. Stone, L. Räber, 2019, Journal of the American College of Cardiology.

Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial

Armando Pérez de Prado, S. Pocock, C. Macaya, 2021, European heart journal.

Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects.

F. Crea, G. Mingrone, S. Brugaletta, 2011, European journal of internal medicine.

Reproducibility of qualitative assessment of stent struts coverage by optical coherence tomography

P. Serruys, H. Garcia-Garcia, N. Bruining, 2012, The International Journal of Cardiovascular Imaging.

Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy

B. Uretsky, G. Campo, S. Brugaletta, 2022, The International Journal of Cardiovascular Imaging.

Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation

L. Räber, A. Kastrati, S. Windecker, 2023, Circulation.

Virtual Histology (VH) for Detecting Necrotic Core (NC)

S. Brugaletta, M. Sabaté, G. Scalone, 2015 .

Assessment of plaque composition by intravascular ultrasound and near-infrared spectroscopy: from PROSPECT I to PROSPECT II.

Manel Sabaté, Salvatore Brugaletta, S. Brugaletta, 2014, Circulation journal : official journal of the Japanese Circulation Society.

Qualitative and quantitative accuracy of ultrasound-based virtual histology for detection of necrotic core in human coronary arteries

Gemma Vilahur, Teresa Padro, Lina Badimon, 2014, The International Journal of Cardiovascular Imaging.

Assessment of Plaque Composition by Intravascular Ultrasound

H. Garcia-Garcia, S. Brugaletta, 2014 .

Endothelial function in coronary chronic total occlusions: need for rigorous methodology.

P. Serruys, H. Garcia-Garcia, S. Brugaletta, 2012, Journal of the American College of Cardiology.

Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial.

R. Whitbourn, P. Serruys, S. Windecker, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Agreement and reproducibility of gray‐scale intravascular ultrasound and optical coherence tomography for the analysis of the bioresorbable vascular scaffold

P. Serruys, H. Garcia-Garcia, B. Gogas, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Rationale and design of the Concordance study between FFR and iFR for the assessment of lesions in the left main coronary artery. The ILITRO-EPIC-07 Trial

O. Rodriguez-Leor, S. Brugaletta, J. Escaned, 2021, REC: interventional cardiology (English Edition).

miRNA Update: A Review Focus on Clinical Implications of miRNA in Vascular Remodeling

S. Brugaletta, M. Sabaté, A. Dantas, 2017 .

Changes in the treatment strategy following intracoronary pressure wire in a contemporaneous real-life cohort of patients with intermediate coronary stenosis. Results from a nationwide registry.

O. Rodriguez-Leor, S. Brugaletta, M. Sabaté, 2022, Cardiovascular revascularization medicine : including molecular interventions.

Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.

A. Jeremias, P. Serruys, G. Niccoli, 2019, JAMA cardiology.

The SYNTAX score and SYNTAX-based clinical risk scores.

P. Serruys, S. Brugaletta, V. Farooq, 2011, Seminars in thoracic and cardiovascular surgery.

Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.

P. Serruys, L. Räber, A. Íñiguez, 2017, JACC. Cardiovascular interventions.

Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2012, European heart journal.

The influence of Elixhauser comorbidity index on percutaneous coronary intervention outcomes

D. Fischman, S. Brugaletta, C. Kwok, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents.

P. Serruys, L. Räber, S. Garg, 2011, The American journal of cardiology.

A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.

E. Steyerberg, M. Mack, P. Serruys, 2012, JACC: Cardiovascular Interventions.

Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.

W. Rottbauer, D. Wood, S. Windecker, 2019, JACC. Cardiovascular interventions.

Rationale and design of the Hunting for the off‐target propertIes of Ticagrelor on Endothelial function and other Circulating biomarkers in Humans (HI‐TECH) trial

S. Windecker, M. Valgimigli, K. M. Akkerhuis, 2017, American heart journal.

Adenosine and Ticagrelor Plasma Levels in Patients With and Without Ticagrelor-Related Dyspnea.

S. Windecker, M. Valgimigli, K. M. Akkerhuis, 2018, Circulation.

Durable polymer everolimus-eluting stents: history, current status and future prospects

S. Brugaletta, L. Ortega‐Paz, J. Rodríguez-Arias, 2020, Expert review of medical devices.

Impact of Aging on Radial Spasm During Coronary Catheterization.

A. Regueiro, D. Fernández-Rodríguez, S. Brugaletta, 2015, The Journal of invasive cardiology.

Randomized Comparison Between Polymer-Free Versus Polymer-Based Paclitaxel-Eluting Stent: Two-Year Final Clinical Results

S. Brugaletta, V. Martin-Yuste, M. Sabaté, 2014, Circulation. Cardiovascular interventions.

Special Management of Diabetic Patients with STEMI

S. Brugaletta, M. Sabaté, 2010 .

Selective use of contemporary drug-eluting stents in primary angioplasty for ST-elevation myocardial infarction: pooled analysis of COMFORTABLE AMI and EXAMINATION.

P. Serruys, L. Räber, A. Baumbach, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry

D. Fernández-Rodríguez, S. Brugaletta, M. Sabaté, 2022, PloS one.

Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate.

F. Burzotta, Massimo Siviglia, G. Niccoli, 2008, Atherosclerosis.

Proximal and distal maximal luminal diameters as a guide to appropriate deployment of the ABSORB everolimus‐eluting bioresorbable vascular scaffold

R. Whitbourn, P. Serruys, H. Garcia-Garcia, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Endothelial function impairment in STEMI patients with out-of-hospital cardiac arrest under therapeutic hypothermia treatment.

M. Roqué, S. Brugaletta, M. Masotti, 2017, International journal of cardiology.

Gender gap in medical care in ST segment elevation myocardial infarction networks: Findings from the Catalan network Codi Infart

A. Regueiro, D. Fernández-Rodríguez, S. Brugaletta, 2017 .

Modulation of CD4+CD28null T Lymphocytes by Tumor Necrosis Factor-&agr; Blockade in Patients With Unstable Angina

A. Rebuzzi, F. Crea, S. Brugaletta, 2006, Circulation.

Expansion of CD4CD28 T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus

F. Crea, S. Brugaletta, S. Giubilato, 2011 .

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score.

J. Mehilli, C. Di Mario, A. Colombo, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Nitric-oxide coated bioactive titanium stents: safer and more effective than second-generation drug-eluting stents?

S. Brugaletta, M. Sabaté, 2014, Revista espanola de cardiologia.

Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.

R. Whitbourn, P. Serruys, S. Windecker, 2011, JACC. Cardiovascular interventions.

NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography.

Patrick W Serruys, Evelyn Regar, Roberto Diletti, 2011, JACC. Cardiovascular imaging.

Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold Thrombosis.

P. Serruys, G. Stone, S. Ellis, 2017, JACC. Cardiovascular interventions.

Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial

P. Serruys, L. Räber, A. Íñiguez, 2015, European heart journal.

Second generation drug-eluting stents: a focus on safety and efficacy of current devices

S. Brugaletta, F. Spione, 2021, Expert review of cardiovascular therapy.

Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Evolut PRO/PRO+ Self-Expanding Valves: Insights From the NEOPRO/NEOPRO-2 Registries

W. Rottbauer, S. Windecker, A. Colombo, 2023, Circulation. Cardiovascular interventions.

Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial

E. Boersma, M. Lenzen, S. Brugaletta, 2023, The Lancet.

Tissue characterization using virtual histology and iMAP: Current status and potential clinical applications

H. Garcia-Garcia, S. Brugaletta, 2012 .

Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold

R. Whitbourn, P. Serruys, S. Garg, 2011, The International Journal of Cardiovascular Imaging.

Assessment of drug-eluting stents and bioresorbable stents by grayscale IVUS and IVUS-based imaging modalities

H. Garcia-Garcia, S. Brugaletta, J. Costa, 2011, The International Journal of Cardiovascular Imaging.

Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study.

P. Serruys, A. Íñiguez, M. Lenzen, 2023, American heart journal.

Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial.

P. Serruys, A. Íñiguez, M. Valgimigli, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction.

P. Serruys, A. Íñiguez, M. Valgimigli, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application.

R. Virmani, P. Serruys, S. Windecker, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Bioresorbable vascular scaffolds technology: current use and future developments

Manel Sabaté, Salvatore Brugaletta, S. Brugaletta, 2016, Medical devices.

Bioresorbable vascular scaffolds in clinical practice: state-of-the-art.

S. Brugaletta, M. Sabaté, M. Hernández-Enríquez, 2016, Panminerva medica.

Bioresorbable vascular scaffold implantation in acute coronary syndromes: clinical evidence, tips and tricks

Manel Sabaté, Salvatore Brugaletta, S. Brugaletta, 2015, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study.

R. Whitbourn, P. Serruys, S. Garg, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A serial 3- and 9-year optical coherence tomography assessment of vascular healing response to sirolimus- and paclitaxel-eluting stents

J. Jąkała, S. Brugaletta, M. Tomaniak, 2018, The International Journal of Cardiovascular Imaging.

Editorial Nitric-oxide Coated Bioactive Titanium Stents : Safer and More Effective Than Second-generation Drug-eluting Stents ?

S. Brugaletta, M. Sabaté, 2019 .

Stent bioactivo de titanio y oxido nitrico, ? ´ s seguro y eficaz que los stents farmacoactivos de segunda generacion? Nitric-oxide Coated Bioactive Titanium Stents: Safer and More Effective Than Second-generation Drug-eluting Stents?

S. Brugaletta, M. Sabaté, 2016 .

Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study.

S. Brugaletta, V. Martin-Yuste, M. Masotti, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Impact of overlapping on 1‐year clinical outcomes in patients undergoing everolimus‐eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST‐EU registry

J. Mehilli, C. Di Mario, A. Colombo, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Overtime evaluation of the vascular HEALing process after everolimus-eluting stent implantation by optical coherence tomography. The HEAL-EES study.

S. Brugaletta, V. Martin-Yuste, M. Masotti, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Gender gap in medical care in ST segment elevation myocardial infarction networks: Findings from the Catalan network Codi Infart.

A. Regueiro, D. Fernández-Rodríguez, S. Brugaletta, 2017, Medicina intensiva.

First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial.

V. Ribeiro, P. Serruys, A. Íñiguez, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Five-Year Optical Coherence Tomography in Patients With ST-Segment–Elevation Myocardial Infarction Treated With Bare-Metal Versus Everolimus-Eluting Stents

S. Brugaletta, V. Martin-Yuste, M. Masotti, 2016, Circulation. Cardiovascular interventions.

Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments.

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2012, Circulation journal : official journal of the Japanese Circulation Society.

Morphological and functional evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS, echogenicity and vasomotion testing at two year follow-up: a patient level insight into the ABSORB A clinical trial

Yoshinobu Onuma, Evelyn Regar, Nico Bruining, 2010, The International Journal of Cardiovascular Imaging.

Coronary endothelial and microvascular function distal to polymer-free and endothelial cell-capturing drug-eluting stents. The randomized FUNCOMBO trial.

S. Brugaletta, M. Sabaté, J. Ferreiro, 2021, Revista espanola de cardiologia.

Zotarolimus for the treatment of coronary artery disease: pathophysiology, DES design, clinical evaluation and future perspective

F. Burzotta, S. Brugaletta, M. Sabaté, 2009, Expert opinion on pharmacotherapy.

Target lesion revascularisation of bioresorbable metal scaffolds: a case series study and literature review

S. Brugaletta, M. Sabaté, F. Alfonso, 2021, EuroIntervention.

Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-Segment Elevation Myocardial Infarction: vascular healing outcomes from the MAGSTEMI trial.

A. Íñiguez, A. Regueiro, S. Brugaletta, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Second-generation drug-eluting absorbable metal scaffold target-lesion revascularization: an optical coherence tomography case series study and literature review.

H. Garcia-Garcia, S. Brugaletta, M. Sabaté, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?

Bernard Chevalier, Patrick W Serruys, Richard Rapoza, 2012, Atherosclerosis.

Plaque compositional Syntax score: combining angiography and lipid burden in coronary artery disease.

P. Serruys, H. Garcia-Garcia, S. D. de Boer, 2012, JACC. Cardiovascular imaging.

Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study.

G. Campo, S. Brugaletta, E. Cerrato, 2019, JACC. Cardiovascular interventions.

How to SORT OUT an Additional Value From Noninferiority Stent Comparisons?

S. Brugaletta, M. Sabaté, 2019, JACC. Cardiovascular interventions.

Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold

R. Whitbourn, P. Serruys, S. Windecker, 2011, The International Journal of Cardiovascular Imaging.

Tools & techniques: risk stratification and diagnostic tools in left main stem intervention.

P. Serruys, L. Räber, H. Garcia-Garcia, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

New percutaneous interventions in heart failure.

S. Brugaletta, M. Sabaté, E. Moscarella, 2019, Minerva cardioangiologica.

Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis: Multistudy Registry Results.

P. Serruys, G. Stone, S. Ellis, 2018, JACC. Cardiovascular interventions.

Relationship between palpography and virtual histology in patients with acute coronary syndromes.

P. Serruys, G. Stone, H. Garcia-Garcia, 2012, JACC. Cardiovascular imaging.

Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves.

W. Rottbauer, D. Wood, M. Metra, 2023, JACC. Cardiovascular interventions.

Impact of Diabetes on 10‐Year Outcomes Following ST‐Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION‐EXTEND Trial

P. Serruys, A. Íñiguez, M. Lenzen, 2022, Journal of the American Heart Association.

Morphology of coronary artery lesions assessed by virtual histology intravascular ultrasound tissue characterization and fractional flow reserve

P. Serruys, H. Garcia-Garcia, W. Wijns, 2012, The International Journal of Cardiovascular Imaging.

Device specificity of vascular healing following implantation of bioresorbable vascular scaffolds and bioabsorbable polymer metallic drug-eluting stents in human coronary arteries: the ESTROFA OCT BVS vs. BP-DES study.

S. Brugaletta, J. Escaned, F. Alfonso, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Treatment of Slow‐Flow After Primary Percutaneous Coronary Intervention With Flow‐Mediated Hyperemia: The Randomized RAIN‐FLOW Study

S. Brugaletta, J. Ferreiro, J. Gómez-Lara, 2023, medRxiv.

CORONARY ARTERY DISEASE Original Studies A 12–Month Angiographic and Optical Coherence Tomography Follow-up After Bioresorbable Vascular Scaffold Implantation in Patients with ST-Segment Elevation Myocardial Infarction

J. Jąkała, S. Brugaletta, M. Tomaniak, 2015 .

Non-Pharmacological Stroke Prevention in Atrial Fibrillation

A. Regueiro, S. Brugaletta, X. Freixa, 2023, Journal of clinical medicine.

TCT-564 Monocenter registry of 1248 consecutive patients with a coronary chronic total occlusion: predictor factors of cardiac death

A. Regueiro, S. Brugaletta, X. Freixa, 2017 .

Reproducibility of intravascular ultrasound radiofrequency data analysis (virtual histology) with a 45-MHz rotational imaging catheter in ex vivo human coronary arteries.

P. Serruys, H. Garcia-Garcia, A. Nair, 2015, Journal of cardiology.

CORONARY ARTERY DISEASE Original Studies Reproducibility of Intravascular Ultrasound iMAP for Radiofrequency Data Analysis: Implications for Design of Longitudinal Studies

H. Garcia-Garcia, S. Brugaletta, J. Gómez-Lara, 2014 .

Timing of Complete Multivessel Revascularization in Patients Presenting with Non-ST-Elevation Acute Coronary Syndrome

C. V. van Mieghem, M. Lenzen, S. Brugaletta, 2023, medRxiv.

Cost-Effectiveness of Percutaneous Coronary Intervention with cobalt-Chromium Everolimus Eluting Stents versus Bare Metal Stents : Results from a Patient Level meta-Analysis of Randomized Trials

F. Eberli, P. Serruys, M. Valgimigli, 2016 .

Cost-Effectiveness of Drug-Eluting Stents in Elderly Patients With Coronary Artery Disease: The SENIOR Trial

S. Cook, I. Durand-zaleski, P. Sinnaeve, 2019, Value in Health.

Disparate miRNA expression in serum and plasma of patients with acute myocardial infarction: a systematic and paired comparative analysis

C. Hermenegildo, S. Brugaletta, M. Sabaté, 2020, Scientific Reports.

Percutaneous vs surgical axillary access for transcatheter aortic valve implantation: the TAXI registry.

M. Niemelä, E. Romagnoli, C. Trani, 2022, Panminerva medica.

Lipid core burden index and Framingham score: can a Systemic Risk Score predict lipid core burden in non-culprit coronary artery?

P. Serruys, H. Garcia-Garcia, S. D. de Boer, 2012, International journal of cardiology.

Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials.

L. Räber, A. Íñiguez, A. Baumbach, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

P. Serruys, H. Garcia-Garcia, S. D. de Boer, 2014, European heart journal.

TCT-208 Comparison Of Antithrombotic Regimens For Primary Angioplasty In Patients > 75 Years With ST Elevated Myocardial Infarction: The ESTROFA-MI+75 Study

S. Brugaletta, F. Alfonso, J. Sanchis, 2015 .

Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial

M. Valgimigli, A. Santarelli, C. Briguori, 2015, The Lancet.

R. Ferrari, M. Valgimigli, G. Campo, 2009, Circulation.

Darapladib effect on circulating high sensitive troponin in patients with acute coronary syndromes.

P. Serruys, H. Garcia-Garcia, E. Boersma, 2012, Atherosclerosis.

A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.

E. Steyerberg, M. Mack, P. Serruys, 2012, JACC. Cardiovascular interventions.

Paradoxical preservation of vascular function in severe obesity.

F. Crea, S. Brugaletta, C. Guidone, 2010, The American journal of medicine.

Thrombectomy and Stroke: Guilty or Innocent Bystander?

S. Brugaletta, M. Sabaté, 2018, Journal of the American College of Cardiology.

Radial versus femoral access for angioplasty of ST-segment elevation acute myocardial infarction with second-generation drug-eluting stents.

P. Serruys, A. Íñiguez, S. Brugaletta, 2015, Revista espanola de cardiologia.

Letter by Brugaletta et al. regarding article, "Interference of drug-eluting stents and endothelium-dependent coronary vasomotion: evidence for device-specific responses".

S. Brugaletta, M. Sabaté, V. M. Yuste, 2009, Circulation. Cardiovascular interventions.

Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial.

G. Campo, S. Brugaletta, M. Tebaldi, 2020, Minerva cardioangiologica.

Validation of the all-comers design: Results of the TARGET-AC substudy.

A. Baumbach, A. Lansky, W. Wijns, 2019, American heart journal.

Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology

A. Budaj, H. Bueno, K. Huber, 2023, European heart journal. Quality of care & clinical outcomes.

Presentation, care and outcomes of patients with NSTEMI according to World Bank country income classification: Prospective international multicentre cohort study of the ESC EORP NSTEMI registry

K. Huber, C. Gale, V. Kunadian, 2023, European Heart Journal: Acute Cardiovascular Care.

Cohort Profile: The ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.

A. Budaj, H. Bueno, K. Huber, 2022, European heart journal. Quality of care & clinical outcomes.

TCT-12 Impact of overlap on long-term clinical outcomes in patients undergoing everolimus-eluting bioresorbable vascular scaffolds implantation in routine clinical practice: insights from the European multicenter GHOST-EU registry

J. Mehilli, A. Colombo, S. Brugaletta, 2015 .

Impact of Body Mass Index on 5-Year Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction After Everolimus-Eluting or Bare-Metal Stent Implantation.

P. Serruys, A. Íñiguez, M. Valgimigli, 2017, The American journal of cardiology.

First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial.

V. Ribeiro, P. Serruys, A. Íñiguez, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm.

R. Whitbourn, P. Serruys, S. Windecker, 2011, Journal of the American College of Cardiology.

A. Jeremias, P. Serruys, G. Niccoli, 2018, JACC. Cardiovascular interventions.

Changes in the treatment strategy following intracoronary pressure wire in a contemporaneous real-life cohort of patients with intermediate coronary stenosis. Results from a nationwide registry.

O. Rodriguez-Leor, S. Brugaletta, M. Sabaté, 2023, Cardiovascular revascularization medicine : including molecular interventions.

Clinical outcomes following different stenting techniques for coronary bifurcation lesions: a systematic review and network meta-analysis of randomised controlled trials.

S. Brugaletta, M. Sabaté, G. Stanković, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Immediate versus staged complete revascularization in acute coronary syndrome: A meta-analysis of randomized controlled trials.

S. Brugaletta, M. Sabaté, R. Diletti, 2023, International journal of cardiology.

NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography.

P. Serruys, J. Wykrzykowska, H. Garcia-Garcia, 2011, JACC. Cardiovascular imaging.

Timing of Complete Multivessel Revascularization in Patients Presenting With Non-ST-Segment Elevation Acute Coronary Syndrome.

M. Lenzen, S. Brugaletta, C. Schotborgh, 2024, JACC. Cardiovascular interventions.

The Role of Virtual Histology Intravascular Ultrasound in the Identification of Coronary Artery Plaque Vulnerability in Acute Coronary Syndromes

A. Nair, G. Mintz, V. Kunadian, 2016, Cardiology in review.

Randomized Comparison Between Polymer-Free Versus Polymer-Based Paclitaxel-Eluting Stent: Two-Year Final Clinical Results

S. Brugaletta, V. Martin-Yuste, M. Sabaté, 2014, Circulation. Cardiovascular Interventions.

Overtime evaluation of the vascular HEALing process after everolimus-eluting stent implantation by optical coherence tomography. The HEAL-EES study.

S. Brugaletta, V. Martin-Yuste, M. Masotti, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Edge vascular response after polymer-free vs. polymer-based paclitaxel-eluting stent implantation.

S. Brugaletta, V. Martin-Yuste, M. Sabaté, 2014, Circulation journal : official journal of the Japanese Circulation Society.

A serial three- and nine-year optical coherence tomography evaluation of neoatherosclerosis progression after sirolimus- and paclitaxel- -eluting stent implantation.

J. Jąkała, S. Brugaletta, M. Tomaniak, 2018, Kardiologia polska.

Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study.

S. Brugaletta, V. Martin-Yuste, M. Masotti, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Transcatheter aortic valve implantation in patients with left main percutaneous coronary intervention.

S. Brugaletta, V. Martin-Yuste, M. Masotti, 2013, The Journal of heart valve disease.

Decision-Making in a Long Lesion: Full Metal Jacket or Spot Stenting?

S. Brugaletta, 2016 .

Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial.

A. Íñiguez, S. Brugaletta, Á. Cequier, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.